155 related articles for article (PubMed ID: 7681913)
1. Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model.
Shimizu A; Kaibara M; Centurion OA; Kapuku G; Hirata T; Fukatani M; Yano K; Hashiba K
J Cardiovasc Pharmacol; 1993 Apr; 21(4):656-62. PubMed ID: 7681913
[TBL] [Abstract][Full Text] [Related]
2. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine terminates atrial flutter and fibrillation in a canine model.
Bhimani AA; Yasuda T; Sadrpour SA; Khrestian CM; Lee S; Zeng D; Belardinelli L; Waldo AL
Heart Rhythm; 2014 Sep; 11(9):1592-9. PubMed ID: 25066042
[TBL] [Abstract][Full Text] [Related]
4. Termination of Atrial Flutter and Fibrillation by K201's Metabolite M-II: Studies in the Canine Sterile Pericarditis Model.
Sadrpour SA; Serhal M; Khrestian CM; Lee S; Fields T; Dittrich HC; Waldo AL
J Cardiovasc Pharmacol; 2015 May; 65(5):494-9. PubMed ID: 25636078
[TBL] [Abstract][Full Text] [Related]
5. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.
Goldstein RN; Khrestian C; Carlsson L; Waldo AL
J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1444-50. PubMed ID: 15610294
[TBL] [Abstract][Full Text] [Related]
6. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap.
Inoue H; Yamashita T; Nozaki A; Sugimoto T
J Am Coll Cardiol; 1991 Oct; 18(4):1098-104. PubMed ID: 1910060
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of interruption of atrial flutter by moricizine. Electrophysiological and multiplexing studies in the canine sterile pericarditis model of atrial flutter.
Ortiz J; Nozaki A; Shimizu A; Khrestian C; Rudy Y; Waldo AL
Circulation; 1994 Jun; 89(6):2860-9. PubMed ID: 8205702
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model.
Buchanan LV; LeMay RJ; Walters RR; Hsu CY; Brunden MN; Gibson JK
J Cardiovasc Electrophysiol; 1996 Feb; 7(2):113-9. PubMed ID: 8853021
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model.
Kumagai K; Nakashima H; Gondo N; Saku K
J Cardiovasc Electrophysiol; 2003 Aug; 14(8):880-4. PubMed ID: 12890053
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: comparison with the effects of quinidine.
Okumura K; Waldo AL
J Am Coll Cardiol; 1987 Jun; 9(6):1332-8. PubMed ID: 2438320
[TBL] [Abstract][Full Text] [Related]
11. Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results.
Cakulev I; Lacerda AE; Khrestian CM; Ryu K; Brown AM; Waldo AL
J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1266-73. PubMed ID: 21615815
[TBL] [Abstract][Full Text] [Related]
12. Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis.
Pagé PL; Hassanalizadeh H; Cardinal R
Can J Physiol Pharmacol; 1991 Jan; 69(1):15-24. PubMed ID: 2036596
[TBL] [Abstract][Full Text] [Related]
13. Acute intravenous conversion of canine atrial flutter: comparison of antiarrhythmic agents.
Buchanan LV; Kabell G; Gibson JK
J Cardiovasc Pharmacol; 1995 Apr; 25(4):539-44. PubMed ID: 7596120
[TBL] [Abstract][Full Text] [Related]
14. Effects of N-acetylprocainamide and recainam in the pharmacologic conversion and suppression of experimental canine atrial flutter: significance of changes in refractoriness and conduction.
Feld GK; Venkatesh N; Singh BN
J Cardiovasc Pharmacol; 1988 May; 11(5):573-80. PubMed ID: 2455844
[TBL] [Abstract][Full Text] [Related]
15. Inhomogeneity in the appearance of electrical remodeling during chronic rapid atrial pacing: evaluation of the dispersion of atrial effective refractoriness.
Moriguchi M; Niwano S; Yoshizawa N; Kitano Y; Kojima J; Inuo K; Saitou J; Izumi T
Jpn Circ J; 2001 Apr; 65(4):335-40. PubMed ID: 11316134
[TBL] [Abstract][Full Text] [Related]
16. Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide.
Wang J; Feng J; Nattel S
Circulation; 1994 Oct; 90(4):2032-40. PubMed ID: 7923691
[TBL] [Abstract][Full Text] [Related]
17. Verapamil suppresses the inhomogeneity of electrical remodeling in a canine long-term rapid atrial stimulation model.
Moriguchi M; Niwano S; Yoshizawa N; Kojima J; Inuo K; Izumi T
Pacing Clin Electrophysiol; 2003 Nov; 26(11):2072-82. PubMed ID: 14622307
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic effects of SD-3212, a new class I antiarrhythmic drug, on canine atrial flutter and atrial action-potential characteristics.
Fujiki A; Tani M; Hayashi H; Mizumaki K; Inoue H; Uemura H; Nakaya H
J Cardiovasc Pharmacol; 1997 Apr; 29(4):471-5. PubMed ID: 9156356
[TBL] [Abstract][Full Text] [Related]
19. Clinical assessment of antiarrhythmic agents for paroxysmal atrial fibrillation guided by modification of electrophysiologic arrhythmogenicity.
Sasano T; Okishige K; Azegami K; Isobe M
J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1250-7. PubMed ID: 15574173
[TBL] [Abstract][Full Text] [Related]
20. A new animal model of atrial flutter.
Pagé PL; Plumb VJ; Okumura K; Waldo AL
J Am Coll Cardiol; 1986 Oct; 8(4):872-9. PubMed ID: 3760359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
